Companies
- Companies
- Company details
Mediolanum farmaceutici SpA
Out-licensing
A Novel Synthetic Growth Hormone Releasing Peptide that Stimulates Growth Hormone Secretion: Hexarelin to Treat GH Secretory Deficiencies and Congestive Heart Failure More
Dermatan Sulphate (DS) as a Novel Antithrombotic Drug for the Treatment of Deep Vein Thrombosis (DVT) More
Phase II Clinical Trial Completed for Avorelin: A Promising LHRH Superagonist for Treatment of Hormone Sensitive Cancers and Endometriosis More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 22 pages - $99
Nov 2010 - 22 pages - $125
Nov 2010 - 211 pages - $600
Jul 2011 - 52 pages - $500
Dec 2010 - 61 pages - $500
Jul 2010 - 44 pages - $750
May 2011 - 15 pages - $125
Sep 2010 - 94 pages - $795
Mar 2011 - 26 pages - $125
Jun 2011 - 29 pages - $125
Contact details
Mrs Cristina Del Bono
Business Development
International Opertaions & Licensing
Head office
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us